Archives

Vanessa Malier

Vanessa has more than 25 years of professional experience in the healthcare industry, in leadership roles in pharma, biotech and...
View Article

Daniel Guay

Daniel is a seasoned leader in drug discovery with over 35 years of experience in the industry and a strong...
View Article

Jade Dagher

Jade is an accomplished life sciences executive with over 30 years of leadership experience in the pharmaceutical and healthcare industries....
View Article

Dr Allan Jordan

Allan joined Sygnature Discovery in February 2019 and is Vice President of Oncology Drug Discovery. Allan has over 25 years...
View Article

Dr John Unitt

John joined Sygnature in August 2011 from AstraZeneca to establish and lead the Bioscience group. Under his leadership, the Bioscience...
View Article

Dr Max Mirza

Max is a highly-experienced neuroscientist whose career spans over 25 years in biotech as well as big- and mid-size pharma....
View Article

Dr Stephen Young

Stephen joined Sygnature in January 2016 from Hitgen where he was Vice President of Business Development, establishing several early research...
View Article

Malken Bayrakdarian

Malken is a seasoned pharmaceutical leader with extensive experience in preclinical research development and driving innovation, compliance, and growth through...
View Article

Fraser McIntosh

Fraser joined Sygnature Discovery in January 2025 as Vice President, In Vivo Pharmacology. He brings 30 years of experience in...
View Article

Dr Emily Eaton

Emily joined Sygnature in 2012 and has held a number of scientific and commercial roles within the business prior to...
View Article

David Claveau

David is a seasoned business development professional with over 25 years of experience in the pharmaceutical and biotech industries. He...
View Article

David Dalrymple

David has over 15 years commercial experience in early-stage drug discovery, having started his career as a Business Development Manager...
View Article